UBS Maintains Neutral on Marathon Oil, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Josh Silverstein maintains a Neutral rating on Marathon Oil (NYSE:MRO) and lowers the price target from $32 to $30.
August 13, 2024 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst Josh Silverstein maintains a Neutral rating on Marathon Oil and lowers the price target from $32 to $30.
The lowered price target from $32 to $30 by UBS suggests a slightly less optimistic outlook for Marathon Oil, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100